Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) Article

sustainable development goals

SDG 03: Good Health and Well-being

publication date

July 1, 2016

webpage

Web of Science

published in

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY Journal

start page

1148

end page

1158

volume

30

issue

7